(1553–1591) Systemic Sclerosis & Related Disorders – Clinical Poster II

Monday, October 27, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

A Novel Endothelial Cell Profiling Assay to Identify Systemic Sclerosis Patient Characteristics at the Endothelial Cell Level
Abstract Poster Presenter: Eva Hoekstra, MD,MSc (she/her/hers) – Leiden University Medical Center
10:30 AM - 12:30 PM Central Time

A Rise in Serum KL-6 Levels Predicts Subsequent Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis-associated Interstitial Lung Disease
Abstract Poster Presenter: Keina Yomono, MD – Nippon Medical School
10:30 AM - 12:30 PM Central Time

Anti-cytolethal Distending Toxin Antibodies in Systemic Sclerosis: Associations with Gastrointestinal Disease and Immune Dysregulation
Abstract Poster Presenter: Ashish Balar, MBBS, MPH – The University of Texas Health Science Center Houston
10:30 AM - 12:30 PM Central Time

Association Between Thoracic Muscle and Fat Area and Density and Pulmonary Function in Systemic Sclerosis
Abstract Poster Presenter: Aradhna Agarwal, MD, MPH – Columbia University
10:30 AM - 12:30 PM Central Time

Association of Levels of Soluble CD13 with Clinical Features and Fibrosis in Systemic Sclerosis Patients
Abstract Poster Presenter: Yuzo Ikari, MD, PhD – Division of Rheumatology, Department of Medicine, Showa Medical University School of Medicine
10:30 AM - 12:30 PM Central Time

Association of the Gastrointestinal (GI) Microbiome and GI Symptoms in Systemic Sclerosis: An International, Multi-center, Observational Study
Abstract Poster Presenter: Elizabeth Volkmann, MD, MS – University of California, Los Angeles
10:30 AM - 12:30 PM Central Time

Can We Use Patient Reported Outcomes For Home-monitoring in SSc?
Abstract Poster Presenter: Eva Hoekstra, MD,MSc (she/her/hers) – Leiden University Medical Center
10:30 AM - 12:30 PM Central Time

Circulating Monocyte Level Is Associated With Pulmonary Vascular Disease and Right Ventricular Dysfunction in Systemic Sclerosis
Abstract Poster Presenter: Ai Yaku, MD, PhD – Northwestern University
10:30 AM - 12:30 PM Central Time

Clinical presentation, course, treatment and outcome of juvenile onset versus adult onset mixed connective tissue disease patients: a multicenter retrospective cohort.
Abstract Poster Presenter: Kevin Chevalier – Université Paris Cité
10:30 AM - 12:30 PM Central Time

Compromised intracellular oxygen availability and severe mitochondrial dysfunction in the skeletal muscle of patients with systemic sclerosis
Abstract Poster Presenter: Tracy Frech, MD, MS – Vanderbilt University Medical Center
10:30 AM - 12:30 PM Central Time

Deep-learning analysis of HRCT images predicts progression and mortality in systemic sclerosis-related interstitial lung disease
Abstract Poster Presenter: Enrico De Lorenzis, MD,PhD – Catholic University of the Sacred Heart
10:30 AM - 12:30 PM Central Time

Demographic, Clinical, and Mortality Trends in Scleroderma Patients with Gastric Antral Vascular Ectasia (GAVE): A National Inpatient Analysis
Abstract Poster Presenter: Akanksha Sharma, MD (she/her/hers) – UPMC Mercy Hospital
10:30 AM - 12:30 PM Central Time

Epidemiology, Outcome and Expenditures of Hospitalized Patients with Systemic Sclerosis: National Inpatient Sample 2021
Abstract Poster Presenter: Patompong Ungprasert, MD, MS – Cleveland Clinic, Cleveland, OH
10:30 AM - 12:30 PM Central Time

Evaluation of Adverse Childhood Experiences in Systemic Sclerosis: Prevalence and Patient Characteristics
Abstract Poster Presenter: Samuel Good, MD – University of California, Los Angeles
10:30 AM - 12:30 PM Central Time

Exploring the Pulmonary Vascular Changes on Computed Tomography in predicting progression and mortality of Systemic Sclerosis-associated Interstitial Lung Disease
Abstract Poster Presenter: Maria Iacovantuono, MD – Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University, Rome, Italy
10:30 AM - 12:30 PM Central Time

Factors Associated with Patient and Physician Global Assessments in Early Systemic Sclerosis
Abstract Poster Presenter: Ellen Romich, MD, MSCE – University of Pennsylvania
10:30 AM - 12:30 PM Central Time

Gastrointestinal Symptom Severity Is Associated with Worse Patient-reported Outcomes and Dietary Patterns in Systemic Sclerosis: A Single Center Prospective Study
Abstract Poster Presenter: Ashima Makol, MD – Mayo Clinic, Rochester, MN
10:30 AM - 12:30 PM Central Time

Hydroxychloroquine and Disease Progression in Systemic Sclerosis: Insights from Antibody-Stratified Survival Analyses
Abstract Poster Presenter: Francesco Bonomi, MD – University Hospital Careggi, Florence
10:30 AM - 12:30 PM Central Time

Impact of COVID-19 Infection on Fibrosis Progression in CTD-Associated ILD: An AI-Based Quantitative CT Study
Abstract Poster Presenter: Kyung Ann Lee, MD, PhD (she/her/hers) – Soonchunhyang University Hospital Seoul: Soonchunhyang University Hospital
10:30 AM - 12:30 PM Central Time

Intravenous cyclophosphamide in the treatment of progressive interstitial lung diseases associated with systemic sclerosis: a prospective randomized trial versus placebo (SCLEROCYC).
Abstract Poster Presenter: Luc Mouthon, MD, PhD – Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Cochin University Hospital, Université Paris Cité, AP-HP
10:30 AM - 12:30 PM Central Time

Latent Profiles of Parenchymal Abnormalities and Vascular Features Measured by Quantitative CT Identifies a Subgroup of Systemic Sclerosis Patients With a Greater Lung Function Decline Over Time
Abstract Poster Presenter: Alicia Hinze, MD, MHS – Mayo Clinic - Rochester, MN
10:30 AM - 12:30 PM Central Time

Longitudinal assessment of circulating fibroblast activation protein in systemic sclerosis-associated interstitial lung disease
Abstract Poster Presenter: Bo Broens, MD – Amsterdam UMC
10:30 AM - 12:30 PM Central Time

Longitudinal Clinical Response to JAK Inhibitors in Systemic Sclerosis: A Real-Life Multicentric Study Across Clinical Domains
Abstract Poster Presenter: Stefano Di Donato, MD – University of Leeds
10:30 AM - 12:30 PM Central Time

Lung Vasculature Quantification on Computed Tomography Predicts New Onset of Interstitial Lung Disease in Systemic Sclerosis
Abstract Poster Presenter: Maria Iacovantuono, MD – Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University, Rome, Italy
10:30 AM - 12:30 PM Central Time

Nintedanib in Systemic Sclerosis-Associated Interstitial Lung disease: Real-World Cohort Study on Tolerability and Discontinuation
Abstract Poster Presenter: Voon Ong, PhD, FRCP – UCL Medical School Royal Free Campus
10:30 AM - 12:30 PM Central Time

Novel autoantibodies in patients with systemic sclerosis and gastrointestinal dysfunction provide insight into disease pathogenesis
Abstract Poster Presenter: Zsuzsanna McMahan, MD, MHS – UT Health Houston
10:30 AM - 12:30 PM Central Time

Prevalence Of Oral Manifestations And Their Association With Clinical And Serological Profile In Systemic Sclerosis Patients- An Indian Study
Abstract Poster Presenter: Tejaswini Ramineni, n/a (she/her/hers) – Esic Medical College And Hospital, Sanathnagar
10:30 AM - 12:30 PM Central Time

Prevalence of Organ Involvement and Baseline Predictors of Disease Progression in Patients with Limited Cutaneous Systemic Sclerosis: Insights from the CONQUER Database
Abstract Poster Presenter: Alain Lescoat, MD, PhD – CHU Rennes - University Rennes
10:30 AM - 12:30 PM Central Time

Real-World Safety and Efficacy of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched EUSTAR Study
Abstract Poster Presenter: Stefano Di Donato, MD – University of Leeds
10:30 AM - 12:30 PM Central Time

RESET-SSc: Clinical Trial Evaluating Rese-cel (Resecabtagene Autoleucel), A Fully Human, Autologous 4-1BB CD19-CAR T Cell Therapy in Systemic Sclerosis
Abstract Poster Presenter: Dinesh Khanna, MD, MSc – University of Michigan
10:30 AM - 12:30 PM Central Time

Risk factors for incident digital ischemic complications in systemic sclerosis in the Collaborative National Quality and Efficacy Registry (CONQUER)
Abstract Poster Presenter: Marissa Savoie, MD – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Spatial Transcriptomics of Perivascular Subepidermal Regions in Very Early Systemic Sclerosis Unveils Cellular and Mitochondrial Stress-Driven Innate Immune Signatures that Initiate Stromal Remodeling
Abstract Poster Presenter: Francesco Del Galdo, MD,PhD – University of Leeds
10:30 AM - 12:30 PM Central Time

The Overall Prevalence and Associated Disease Characteristics of Calcinosis in Systemic Sclerosis: a Systematic Review and Meta-analysis
Abstract Poster Presenter: Marie-Elise Martel, MD – Lille University Hospital, France
10:30 AM - 12:30 PM Central Time

Use of the CD19/CD3 T cell engager blinatumomab in refractory diffuse systemic sclerosis : a case series
Abstract Poster Presenter: Marc Scherlinger, MD,PhD (he/him/his) – Strasbourg University Hospital
10:30 AM - 12:30 PM Central Time

Usefulness of HRCT in screening of interstitial lung disease in patients with systemic sclerosis without risk factors of clinical suspicion
Abstract Poster Presenter: Carlos De la Puente, MD – Ramón y Cajal University Hospital
10:30 AM - 12:30 PM Central Time

Validation of a Composite Endpoint for Systemic Sclerosis-Associated Interstitial Lung Disease
Abstract Poster Presenter: Elizabeth Volkmann, MD, MS – University of California, Los Angeles
10:30 AM - 12:30 PM Central Time

Vasodilation with Prostanoids Influences Progression of Systemic Sclerosis-Associated Interstitial Lung Disease: a EUSTAR Cohort Study
Abstract Poster Presenter: Cosimo Bruni, MD, PhD – University of Zurich
10:30 AM - 12:30 PM Central Time

WITHDRAWN